Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. 1998

K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
3rd Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.

We recently demonstrated that centrally administered melatonin at low doses inhibits the induction of gastric lesions by water-immersion restraint stress. To investigate the mechanism of the potent anti-ulcer action of melatonin, the central nervous system (CNS) effects of melatonin on gastric acid and pepsin secretion were studied in conscious pylorus-ligated rats. Intracisternal (i.c.) melatonin (1-100 ng) dose-dependently decreased acid and pepsin output, while a higher i.p. dose (1 microg) had no inhibitory effect. The i.c. melatonin did not change serum gastrin concentrations. Serum melatonin concentrations at 1 and 4 h after i.c. administration of 10-100 ng melatonin did not differ from those in rats receiving i.c. vehicle. The present results suggest that melatonin administered centrally modulates the secretion of gastric acid and pepsin which may explain, at least in part, the protective, anti-stress role of melatonin in the gastric mucosa observed in our previous study.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D010434 Pepsin A Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice. Pepsin,Pepsin 1,Pepsin 3
D011706 Pyloric Antrum The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS). Antrum, Pyloric,Gastric Antrum,Antrum, Gastric,Antrums, Gastric,Antrums, Pyloric,Gastric Antrums,Pyloric Antrums
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002946 Cisterna Magna One of three principal openings in the SUBARACHNOID SPACE. They are also known as cerebellomedullary cistern, and collectively as cisterns. Magna, Cisterna
D003250 Constriction The act of constricting. Clamping,Clampings,Constrictions
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug

Related Publications

K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
January 1969, Scandinavian journal of gastroenterology,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
March 1970, Research communications in chemical pathology and pharmacology,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
March 1991, Biochemical and biophysical research communications,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
September 1958, Gastroenterology,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
April 1988, Biochemical and biophysical research communications,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
January 1995, Peptides,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
January 1987, Pharmacology,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
June 1995, Pharmacological research,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
August 1995, British journal of pharmacology,
K Kato, and I Murai, and S Asai, and Y Takahashi, and Y Matsuno, and S Komuro, and H Kurosaka, and A Iwasaki, and K Ishikawa, and Y Arakawa
July 1985, Life sciences,
Copied contents to your clipboard!